Pharma Sessions

Pharma Sessions

Download on the App Store

Pharma Sessions episodes

  • How Medical Affairs Becomes the Connector with Sonia Talwar
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve from a reactive support function into a true strategic connector.
    Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
    The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
    Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    26 min
  • Why Manufacturing Is the New Competitive Edge in Cell and Gene Therapy
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO partners, the future of cell and gene therapy manufacturing, and the hard-earned lessons behind building sustainable, high-performance organizations in one of the most complex areas of medicine.
    Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
    The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
    Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    33 min
  • The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 2
    In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug pricing and argue that outcomes-based contracting is the path forward for sustainable profitability and patient access.
    Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
    The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
    Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    22 min
  • The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 1
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. David Shulkin, President of Shulkin Solutions, to discuss what it actually takes to lead through a healthcare crisis at scale. Dr. Shulkin shares insights about the current state of U.S. public health, the intersection of policy and care delivery, the role of innovation and technology, and what must change to better serve patients.
    Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
    The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
    Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    32 min
  • How AI Is Reshaping Pharma’s Commercial Operations with Punit Kumar
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Punit Kumar, the Executive Director of Customer Engagement for the US Enterprise Portfolio at Novartis, to dive into why execution excellence matters more than hype, how AI agents are freeing up your team from manual work to focus on high-impact insights, and the counterintuitive skill that matters most in pharma today: getting comfortable being uncomfortable.
    Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
    The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
    Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    40 min
  • Why Pharma products win or lose years before launch
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Farrell Simon, Chief Commercial Officer at Trevi Therapeutics, to discuss what commercial leadership looks like long before launch, sharing lessons from a career that spans Procter & Gamble, Pfizer, and biotech.
    Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
    The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
    Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    33 min
  • Building a Cancer Medtech Company the Hard Way: Shaun Bagai on Evidence, Strategy, and Growth
    Drug launches in oncology don’t succeed simply because the technology works; they succeed when the evidence is strong enough to change physician behavior. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Shaun Bagai, CEO of RenovoRx, to discuss the long and uncertain journey of building a medtech company grounded in clinical proof. From turning down medical school to leading a Nasdaq-listed oncology company, Shaun shares how physician feedback reshaped the company’s strategy, why investing in rigorous clinical trials can be a defining leadership decision, and why face-to-face relationships remain essential for market adoption in healthcare.
    Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
    The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    33 min
  • How to Actually Get the Stuff You Want Approved in Pharma
    In this solo episode of Pharma Sessions, host Jonathan Kaskey breaks down what actually determines whether a new technology implementation in pharma succeeds or quietly dies in a steering committee meeting. After helping pharma companies implement nearly $200 million in new software platforms over the course of his career, Jonathan shares the patterns he’s seen again and again.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    17 min
  • How SkinPass Went From Bedside Insight to Retail Scale with Dr. Christopher Otiko
    Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side.
    Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
    The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    27 min
  • Why Drug Launches Are Won Years Before Approval with Ana Bozas
    Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    31 min

About Pharma Sessions

From the publisher's feed

Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)

More shows like Pharma Sessions

Freakonomics Radio by Freakonomics Radio + Stitcher

Freakonomics Radio

31,952 Listeners

HBR IdeaCast by Harvard Business Review

HBR IdeaCast

132 Listeners

The Daily by The New York Times

The Daily

112,250 Listeners

The Readout Loud by STAT

The Readout Loud

338 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

62 Listeners